SBC Medical Group (NASDAQ:SBC) Upgraded to Strong-Buy at Wall Street Zen

SBC Medical Group (NASDAQ:SBC - Get Free Report) was upgraded by Wall Street Zen to a "strong-buy" rating in a research report issued on Saturday.

SBC Medical Group Trading Down 7.3%

SBC Medical Group stock traded down $0.34 during trading hours on Friday, hitting $4.31. The stock had a trading volume of 219,380 shares, compared to its average volume of 62,985. The company has a 50-day moving average of $4.04 and a two-hundred day moving average of $4.47. The company has a current ratio of 4.44, a quick ratio of 4.40 and a debt-to-equity ratio of 0.03. SBC Medical Group has a fifty-two week low of $2.62 and a fifty-two week high of $12.50.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last released its quarterly earnings data on Thursday, May 15th. The company reported $0.21 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.11 by $0.10. The firm had revenue of $47.33 million for the quarter, compared to the consensus estimate of $51.52 million. Research analysts predict that SBC Medical Group will post 5.02 earnings per share for the current fiscal year.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.